Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease
Susan Kralisch(University Hospital Leipzig), Mathias Faßhauer(Center for Clinical Research (United States)), Jeannette Seeger(Leipzig University), Michaela Ziegelmeier(Leipzig University), Anette Bachmann, Ulrike Lössner(Leipzig University), Matthias Blüher(Helmholtz Centre for Environmental Research), Michael Stümvoll(University Hospital Leipzig)
Cited by 99
Related Papers
Obesity: global epidemiology and pathogenesis
|Nature Reviews Endocrinology|2019|5.1k
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
|New England Journal of Medicine|2008|2.1k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k